Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo

Peripheral Vertigo Clinical Trial

Official title: Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial

Status Completed

Clinical Trial Summary

This study aims to investigate efficacy of two different intravenous drugs (dimenhydrinate and piracetam) in the symptomatic management of peripheral vertigo.

The patients will be randomized in two groups according to symptomatic treatment modalities:

Dimenhydrinate (100 mg) and piracetam (2 g) will be given in 100 cc normal saline in 30 minutes. Each patient will be asked if her/his vertigo symptoms resolved or not, according to a numeric rating scale (0=no vertigo, 10=worst possible vertigo). The patient will be rate the intensity of symptoms in the following times:

• Numeric rating scale (1 to 10): Admission

• Numeric rating scale (1 to 10): After the study drug (No ambulation)*

• Numeric rating scale (1 to 10): After the study drug (Ambulation)*

• Ambulation refers to head movements or walking in the room, if applicable.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Dizziness
• Peripheral Vertigo
• Vertigo

• NCT number: NCT01890538
• Study type: Interventional
• Source: Kocaeli University
• Status: Completed
• Phase: Phase 4
• Start date: June 2013
• Completion date: May 2014